Pigmented neuroectodermal tumour of infancy: an immunohistochemical study

Area of Science:

• Oncology
• Pathology
• Developmental Biology

Background:

• The pigmented neuroectodermal tumour of infancy (PNTI) is a rare pediatric neoplasm with uncertain origins.
• It typically affects the maxilla and usually follows a benign clinical course.
• Current classification places it within peripheral primitive neuroectodermal tumours.

Observation:

• Histological examination reveals two main cell types: neuroblast-like and melanocyte-like.
• This study presents three cases of PNTI, the first examined using a comprehensive antibody panel.
• Immunohistochemical analysis was performed on these cases.

Findings:

• Neuroblast-like cells showed positive staining for neurone-specific enolase (NSE) but were negative for S-100, neurofilaments, glial fibrillary acidic protein (GFAP), vimentin, cytokeratin, epithelial membrane antigen (EMA), and carcinoembryonic antigen (CEA).
• Melanocyte-like cells stained positively for NSE, vimentin, and cytokeratin, while being negative for S-100, neurofilaments, GFAP, EMA, and CEA.
• These differential marker expressions provide insights into the cellular composition and potential differentiation pathways of PNTI.

Implications:

• The distinct immunohistochemical profiles of the two cell types support their proposed neuroectodermal and melanocytic origins.
• Understanding these cellular components and their differentiation is crucial for accurate diagnosis and classification of PNTI.
• Further research into the histogenesis of PNTI can refine diagnostic criteria and potentially inform therapeutic strategies.